tiprankstipranks
Advertisement
Advertisement

APLS Stock Latest News

Biogen completes acquisition of Apellis Pharmaceuticals
The FlyBiogen completes acquisition of Apellis Pharmaceuticals
2d ago
APLS
BIIB
Apellis Completes Biogen Merger and Goes Private
PremiumCompany Announcements
Apellis Completes Biogen Merger and Goes Private
2d ago
8K
APLS
Remitly Global to replace Apellis in S&P 600 at open on 5/14
PremiumThe Fly
Remitly Global to replace Apellis in S&P 600 at open on 5/14
9d ago
APLS
BIIB
Apellis Updates Executive Separation Plan Amid Biogen Merger
PremiumCompany Announcements
Apellis Updates Executive Separation Plan Amid Biogen Merger
12d ago
8K
APLS
Biogen price target raised to $260 from $246 at Guggenheim
PremiumThe Fly
Biogen price target raised to $260 from $246 at Guggenheim
16d ago
APLS
BIIB
Biogen reports Q1 adjusted EPS $3.57, consensus $2.95
PremiumThe FlyBiogen reports Q1 adjusted EPS $3.57, consensus $2.95
17d ago
APLS
BIIB
Wells Fargo downgrades Apellis to Equal Weight following Biogen’s acquisition
Premium
The Fly
Wells Fargo downgrades Apellis to Equal Weight following Biogen’s acquisition
29d ago
APLS
BIIB
Apellis downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Apellis downgraded to Equal Weight from Overweight at Wells Fargo
29d ago
APLS
Tesla upgraded, AppLovin initiated: Wall Street’s top analyst calls
PremiumThe Fly
Tesla upgraded, AppLovin initiated: Wall Street’s top analyst calls
1M ago
F
BE
Apellis price target raised to $41 from $21 at RBC Capital
PremiumThe Fly
Apellis price target raised to $41 from $21 at RBC Capital
1M ago
APLS
3 Best Trending Stocks, According to Analysts – 4/2/2026
PremiumMarket News
3 Best Trending Stocks, According to Analysts – 4/2/2026
1M ago
NKE
APLS
Apellis price target raised to $41 from $20 at Mizuho
PremiumThe Fly
Apellis price target raised to $41 from $20 at Mizuho
1M ago
APLS
Apellis downgraded to Neutral from Buy at Roth Capital
PremiumThe FlyApellis downgraded to Neutral from Buy at Roth Capital
1M ago
APLS
Disney upgraded, Nike downgraded: Wall Street’s top analyst calls
Premium
The Fly
Disney upgraded, Nike downgraded: Wall Street’s top analyst calls
2M ago
BA
EW
Biogen price target raised to $275 from $250 at Oppenheimer
Premium
The Fly
Biogen price target raised to $275 from $250 at Oppenheimer
2M ago
APLS
BIIB
Apellis downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Apellis downgraded to Neutral from Buy at H.C. Wainwright
2M ago
APLS
Apellis: Hold Rating as Biogen Takeout Caps Upside and CVR Payouts Look Unlikely Under Conservative Syfovre Outlook
PremiumRatings
Apellis: Hold Rating as Biogen Takeout Caps Upside and CVR Payouts Look Unlikely Under Conservative Syfovre Outlook
2M ago
APLS
Apellis downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Apellis downgraded to Neutral from Overweight at JPMorgan
2M ago
APLS
Apellis downgraded to Market Perform from Outperform at Raymond James
PremiumThe Fly
Apellis downgraded to Market Perform from Outperform at Raymond James
2M ago
APLS
Hold Rating on Apellis Reflects Biogen Takeover Cap on Upside and Limited Near-Term Catalysts
PremiumRatingsHold Rating on Apellis Reflects Biogen Takeover Cap on Upside and Limited Near-Term Catalysts
2M ago
APLS
Apellis Pharmaceuticals to be Acquired by Biogen in Merger
Premium
Company Announcements
Apellis Pharmaceuticals to be Acquired by Biogen in Merger
2M ago
8K
APLS
Apellis downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Apellis downgraded to Neutral from Overweight at Cantor Fitzgerald
2M ago
APLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >